EP2588086
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-AMINO-5-FLUORO-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]-1H-QUINOLIN-2-ONE LACTATE MONOHYDRATE.
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.6.2011EP published:
12.9.2018EP application number:
11734043.0
EPO information:
European Patent Register
Max expiry date:
28.6.2031
Title:
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-AMINO-5-FLUORO-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]-1H-QUINOLIN-2-ONE LACTATE MONOHYDRATE.
Timeline
Today
29.6.2011EP application
12.9.2018EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
THAKUR, JeewanAddress:
Basel, CH
Name:
QIU, ZhihuiAddress:
Shanghai, CN
Priority
Number:
10168028Date:
30.6.2010Country:
EP
Classification
Categories:
A61K 9/16, A61K 9/20, A61K 31/496